国际眼科纵览
• 综述 • 上一篇 下一篇
刘欣 曾庆延
收稿日期:
出版日期:
发布日期:
通讯作者:
基金资助:
武汉市卫计委临床医学科研项目(WX13C50);爱尔眼科医院集团科研基金项目(AF2013006)
LIU Xin1, ZENG Qing-yan1,2
Received:
Online:
Published:
Contact:
摘要:
真菌性角膜炎是一种严重的致盲性眼病,近年来治疗真菌性角膜炎新的药物有四代唑类、聚六甲基双胍、钙调磷酸酶抑制剂等,新药物剂型有凝胶缓释剂、克霉唑-β-环糊精等,新的手术方式有角膜胶原交联术、准分子激光治疗性角膜切削术、深板层角膜移植术等。(国际眼科纵览, 2015, 39: 386-390)
Abstract:
Fungal keratitis is a serious blindness leading disease. In recent years, new treatment included new medicines such as fourth generation azoles, poly hexamethylene biguanide, calcineurin inhibitors, and new dosage forms such as mucoadhesive gels and Clotrimazole-β-Cyclodextrin, new operation such as corneal collagen cross-linking, excimer laser phototherapeutic keratectomy, deep lamellar keratoplasty, etc. (Int Rev Ophthalmol, 2015, 39: 386-390)
刘欣 曾庆延. 真菌性角膜炎治疗进展[J]. 国际眼科纵览, doi: 10. 3760/cma. j. issn. 1673-5803. 2015. 06. 006.
LIU Xin1, ZENG Qing-yan1,2. The advances in the treatment of fungal keratitis[J]. International Review of Ophthalmology, doi: 10. 3760/cma. j. issn. 1673-5803. 2015. 06. 006.
0 / / 推荐
导出引用管理器 EndNote|Ris|BibTeX
链接本文: http://www.j-bio.net/CN/10. 3760/cma. j. issn. 1673-5803. 2015. 06. 006
http://www.j-bio.net/CN/Y2015/V39/I6/386